Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular cancer

C R Nichols1

  • 1Division of Hematology/Oncology, Oregon Health Sciences University, Portland, USA.

Current Problems in Cancer
|September 22, 1998
PubMed
Summary
This summary is machine-generated.

This review covers male germ cell tumors, discussing pathology, staging, and treatment. Chemotherapy regimens like BEP are effective, with surgery for residual masses, improving survival rates for many patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malignant Hematologic Disorders Arising from Mediastinal Germ Cell Tumors. A Review of Clinical and Biologic Features.

Leukemia & lymphoma·2016
Same author

Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2002
Same author

Red cell and plasma antioxidant components and atherosclerosis in Japanese quail: a time-course study.

Research communications in molecular pathology and pharmacology·2002
Same author

Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.

Journal of the National Cancer Institute·2001
Same author

Creutzfeldt-Jakob disease in unusually young patients who consumed venison.

Archives of neurology·2001
Same journal

When should the medical oncologist call the surgeon?

Current problems in cancer·2026
Same journal

Clinical impact of a single time-point protocol paired FDG-PET and radioactive iodine scan for comprehensive disease assessment in differentiated thyroid cancer.

Current problems in cancer·2026
Same journal

Patterns of care for older multiple myeloma patients in the U.S.: An analysis of the national cancer database.

Current problems in cancer·2026
Same journal

Too late to fall: Time to PSA nadir and early oncologic failure after cryotherapy and high-intensity focused ultrasound for localized prostate cancer.

Current problems in cancer·2026
Same journal

Artificial intelligence, omics, and biomarkers: Redefining lung cancer early detection.

Current problems in cancer·2026
Same journal

Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma.

Current problems in cancer·2026
See all related articles

Area of Science:

  • Oncology
  • Urology

Background:

  • Male germ cell tumors (GCTs) encompass a range of malignancies with distinct pathological features and clinical presentations.
  • Accurate clinical staging is crucial for determining prognosis and guiding treatment strategies for GCTs.

Purpose of the Study:

  • To provide a comprehensive review of male germ cell tumors, including their pathology, clinical manifestations, and modern staging concepts.
  • To discuss current treatment paradigms, focusing on chemotherapy and surgical interventions for various stages and risk groups of GCTs.

Main Methods:

  • Review of current literature and clinical guidelines on male germ cell tumors.
  • Discussion of treatment protocols, including chemotherapy regimens (e.g., BEP, EP) and surgical approaches (e.g., RPLND).
  • Analysis of the international classification system for risk stratification and prognostic assessment.

Related Experiment Videos

Main Results:

  • The international classification system effectively categorizes patients by prognosis, guiding treatment decisions.
  • Chemotherapy regimens such as cisplatin, etoposide, and bleomycin (BEP) achieve high survival rates (>90%) for good- and intermediate-risk non-seminomatous GCTs.
  • Surgical resection of residual masses is vital for patients with persistent disease after chemotherapy, particularly in poor-risk cases.

Conclusions:

  • Modern treatment strategies combining chemotherapy and surgery, guided by risk stratification, significantly improve outcomes for male germ cell tumors.
  • While effective, chemotherapy carries risks such as etoposide-induced leukemia; late effects like preserved ejaculatory function with specific surgical approaches are also noted.
  • Ongoing research, including trials on high-dose therapy, continues to refine treatment protocols for GCTs.